Icaria
Site unreachableWe can capture 99% of urinary exosome using our nanowire device, and we are now working on early detection of cancer by analyzing miRNA profile extracted from urinary exosome.
What it does
Icaria is a liquid biopsy startup, working on early detection of cancer. Icaria’s mission is to detect cancer early, accurately, and unpainfully. By accomplishing our mission, we want to provide accurate and unpainful early cancer detection method, and create a society that everyone can stay healthy throughout their lifetime. We have invented a nanowire device that can collect more than 99% of urinary exosome. By using this technology, we can extract about 1,300 species of miRNA , which is 5 times more than the conventional method. By analyzing the profile of miRNA by machine learning, we succeeded in creating an algorithm in order to diagnosis cancer.
Next to it in Healthcare and bio · liquid biopsy cancer detection
- コウソミル株式会社Plug and Play
Cosomil is a pharmaceutical company that researches and develops methods for diagnosing early-stage diseases like cancer.
- Craif Inc.Plug and Play
Liquid biopsy startup company. Conducted cancer early diagnosis initiatives / リキッド・バイオプシーのスタートアップ企業。ガンの早期診断の取り組みを実施
- NodexusPlug and Play
Nodexus is democratizing access to live single cells for applications including gene editing, drug development, and more.
- X-ZellY Combinator W15
Early, pain-free cancer detection.
- AI Medical ServicePlug and Play
AI Medical Service is a Tokyo-based company developing AI software to help detect gastric cancer.
- AI Medical ServicePlug and Play
AI Medical Service is a Tokyo-based company developing AI software to help detect gastric cancer.
- LINDA LifetechPlug and Play
LINDA is a platform that helps doctors and healthcare professionals in the early detection of breast cancer
- Liquid Mine, Inc.Plug and Play
Original Tailor-made Liquid Biopsy System based on Clinical Sequencing information